Altria reported a US$4.1 billion write-down on its Juul Labs investment on Thursday, January 20, another sizable charge as the vaping crisis continues to roil the e-cigarette industry, reported The Wall Street Journal.
The company now values its 35% percent stake in the e-cigarette company at US$4.2 billion, a significant drop from the US$12.8 billion it paid in December 2018. Three months ago, Altria, one of the world’s largest tobacco sellers, devalued its investment in Juul by US$4.5 billion.
Altria, the maker of Marlboro cigarettes, stated its fourth-quarter charge was largely because of the growing number of legal cases pending against Juul, which increased by more than 80% percent since the end of October.
Howard Willard, chief executive of Altria, said that despite “the unexpected challenges” Juul faces, the company had made progress in its noncombustible platform with the IQOS e-cigarette and on nicotine pouches.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Regulators Set to Clear Microsoft’s $13B OpenAI Investment
Apr 17, 2024 by
CPI
Biden Pledges to Block US Steel Acquisition by Japanese Firm
Apr 17, 2024 by
CPI
Canada Targets Tech Titans with New Digital Tax in 2024
Apr 17, 2024 by
CPI
EU Privacy Watchdog Calls for Meta to Offer Ad-Free Option
Apr 17, 2024 by
CPI
Japan’s Antitrust Overhaul Targets Tech Titans Like Apple
Apr 17, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – China Edition – Year of the Dragon
Apr 16, 2024 by
CPI
Review Logic and Rules for Concentrations of Undertakings that Do Not Meet the Standard of Notification
Apr 16, 2024 by
CPI
China’s Review of Semiconductor Transactions
Apr 16, 2024 by
CPI
Key Challenges and Tips for Merger Control Filing in China for Listed Companies
Apr 16, 2024 by
CPI
Key Point Review: China SPC Antitrust Judgments in 2023
Apr 16, 2024 by
CPI